Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Copenhagen – page 104

1 429 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Copenhagen at a glance
1 429
clinical trials
  • Research sites8
Type of trial
Recruitment status
Quick filters

1 429 trials in Copenhagen

Open in trial search

Breast cancer

Not recruiting

Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Novartis Pharma AG

Prostate cancer metastatic

Not recruiting

Study of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:European Organisation For Research And Treatment Of Cancer

C3 glomerulopathy

Not recruiting

Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Aliskiren
  • Sponsor:Region Skane

Hereditary motor and sensory neuropathy

Not recruiting

Study on the Safety and Effectiveness of NMD670 for Adults with Charcot-Marie-Tooth Disease Types 1 and 2

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:NMD670
  • Sponsor:NMD Pharma A/S

Type 1 diabetes mellitus

Not recruiting

Study on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes

Registered drug
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years
  • Substances:Colecalciferol
  • Sponsor:Diamyd Medical AB

Chronic lymphocytic leukaemia

Not recruiting

Study on Obinutuzumab, Chlorambucil, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.

Neoplasm

Not recruiting

Study on the Effectiveness of Inavolisib, Atezolizumab, and Entrectinib in Patients with Advanced or Metastatic Solid Tumors

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Alectinib
  • Sponsor:F. Hoffmann-La Roche AG

Endometrial cancer stage III+1

Not recruiting

Study on Dostarlimab, Carboplatin, and Paclitaxel for Patients with Recurrent or Advanced Endometrial Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Tesaro Inc.

Diffuse large B-cell lymphoma+2

Not recruiting

Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Celgene Corp.

Plasma cell myeloma refractory

Not recruiting

Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen Cilag International

Hereditary angioedema with C1 esterase inhibitor deficiency

Not recruiting

Study on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults

Registered drug
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Deucrictibant
  • Sponsor:Pharvaris Netherlands B.V.

Dementia Alzheimer's type+1

Not recruiting

Study of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lecanemab
  • Sponsor:Eisai Limited

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Copenhagen

What the registry says about research in the country

01 Cardiovascular Diseases

Clinical trial activity in København includes cardiovascular diseases, with studies focused on acute heart failure. The research is aimed at improving treatment choices and helping clinicians better manage fluid overload and treatment response.

  • Optimizing care for acute decompensated heart failure
  • Evaluating diuretic treatment strategies
  • Addressing risk of diuretic resistance

These trials support more effective day-to-day management of patients with unstable heart conditions.

02 Digestive System Diseases

Research in digestive system diseases is centered on liver cirrhosis and its complications, especially ascites. The main purpose is to improve treatment planning and identify which patients are most likely to benefit from supportive therapy.

  • Studying cirrhosis with ascites
  • Validating response markers for human albumin therapy
  • Improving personalized treatment decisions

This work may help refine care for people with advanced liver disease.

03 Neoplasms

Trials in the field of neoplasms are examining localised dMMR colon cancer. The research is focused on assessing treatment effectiveness and understanding how well patients respond to newer cancer approaches.

  • Investigating colon cancer treatment response
  • Measuring clinical complete response
  • Supporting more tailored cancer care

These studies aim to strengthen precision treatment for selected colorectal cancer patients.

04 Nervous System Diseases

Clinical research in nervous system diseases involves acute ischemic stroke. The goal is to improve urgent stroke care by comparing treatment approaches and their impact on early neurological recovery.

  • Focusing on emergency stroke management
  • Assessing early neurological improvement
  • Comparing current care with thrombolysis approaches

These trials are designed to support faster, more effective treatment decisions after stroke.

05 Virus Diseases

Research in virus diseases includes work on chronic hepatitis B infection, with studies exploring immune-based approaches and treatment effects. The overall aim is to improve control of long-term viral infection and related liver health.

  • Studying hepatitis B infection
  • Testing new antibody-based therapy concepts
  • Supporting better long-term disease control

These trials reflect active interest in advancing antiviral research in Denmark.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.